MariMed Enters Global Hemp CBD Market with GenCanna

MariMed announced it has invested $30 million in GenCanna, and the companies have created a long-term supply agreement whereby GenCanna will supply hemp to MariMed globally. The partnership expands MariMed’s consumer product development capabilities and strengthens GenCanna’s position as a global supply leader in the hemp CBD industry.

Marimed, a multi-state operator that manages cannabis facilities and branded product lines, intends to create a consumer branding business unit focused on CBD-derived hemp products. Its team has developed facilities in DE, IL, NV, MD, MA, and RI. It currently distributes products in several states, and is expanding to additional markets.

GenCanna is deploying the proceeds of the investment to expand its production capacity, and become a global leader in hemp CBD production, with legal sales throughout the U.S. and internationally.

Grand View Research projects the global industrial hemp market will reach $10 billion by 2025. The Brightfield Group projects the hemp CBD market will reach $22 billion by 2022.

GenCanna’s hemp-derived products are exempted from the Controlled Substances Act.

With the anticipated passage of the Hemp Farming Act of 2018, hemp companies will enjoy the same business environment as any other agricultural company, inclusive of federal banking and financial services, as well as transportation of products across state lines.

Said Steve Bevan, GenCanna President, “We eagerly anticipate the passage of the 2018 Farm Bill, already passed by the U.S. Senate, in the near future. Our efforts to work with government leaders to…enable more farmers to grow hemp, are coming to fruition.”

Source Marimed press release

MariMed Enters Global Hemp CBD Market with GenCanna

Cannin Investment Group: Your Hemp Stocks Experts

Cannin.com is your trusted resource for hemp stocks. Our team of financial experts evaluates all emerging hemp stock investing opportunities. We aggregate hundreds of hours of market research to provide tips on the best hemp stocks for 2020.

Use Cannin as your resource for:

Is it too late to invest in hemp stocks? No! This is the perfect time to invest.

Wall Street analysts expect the global cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in hemp stocks is now.

Are you interested in hemp stocks like GW Pharmaceuticals, Charlotte’s Web, Canopy Growth, or Hemp Inc.?

Are you looking to buy stock in hemp companies or marijuana companies in 2020? Interested in emerging penny hemp stocks? Interested in leveraging the power of algorithmic stock trades to profit from hemp stocks? Looking for the best Canadian cannabis stocks to invest in? We can help.

Predict price movements of hemp stocks several hours in advance with our proprietary algorithmic stock trading software.

+25% Gains in 2020
+49.8% Gains in 2019
Backtested since 2012

At Cannin, we’re so confident you’ll love our algotrading hemp stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best hemp stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In

MariMed Enters Global Hemp CBD Market with GenCanna